Similar articles for PMID: 31519800

Year	Number of Results
1995	1
2005	1
2006	2
2007	2
2008	3
2009	2
2010	2
2011	3
2012	3
2013	6
2014	13
2015	6
2016	14
2017	14
2018	14
2019	13
2020	15
2021	14
2022	12
2023	1

1

A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using ⁶⁸Ga-RGD PET/CT.

Lobeek D, Bouwman FCM, Aarntzen EHJG, Molkenboer-Kuenen JDM, Flucke UE, Nguyen HL, Vikkula M, Boon LM, Klein W, Laverman P, Oyen WJG, Boerman OC, Terry SYA, Schultze Kool LJ, Rijpkema M. Lobeek D, et al. J Nucl Med. 2020 Feb;61(2):270-275. doi: 10.2967/jnumed.119.231167. Epub 2019 Sep 13. J Nucl Med. 2020. PMID: 31519800 Free PMC article. Clinical Trial.

2

Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [⁶⁸Ga]Ga-DOTA-E-[c(RGDfK)]₂ PET/CT.

Lobeek D, Rijpkema M, Terry SYA, Molkenboer-Kuenen JDM, Joosten L, van Genugten EAJ, van Engen-van Grunsven ACH, Kaanders JHAM, Pegge SAH, Boerman OC, Weijs WLJ, Merkx MAW, van Herpen CML, Takes RP, Aarntzen EHJG, Oyen WJG. Lobeek D, et al. Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2647-2655. doi: 10.1007/s00259-020-04766-2. Epub 2020 Mar 20. Eur J Nucl Med Mol Imaging. 2020. PMID: 32198613 Free PMC article.

3

⁶⁸Ga-BBN-RGD PET/CT for GRPR and Integrin α_vβ₃ Imaging in Patients with Breast Cancer.

Zhang J, Mao F, Niu G, Peng L, Lang L, Li F, Ying H, Wu H, Pan B, Zhu Z, Chen X. Zhang J, et al. Theranostics. 2018 Jan 1;8(4):1121-1130. doi: 10.7150/thno.22601. eCollection 2018. Theranostics. 2018. PMID: 29464003 Free PMC article.

4

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

5

Pretreatment PET/CT imaging of angiogenesis based on ¹⁸F-RGD tracer uptake may predict antiangiogenic response.

Li L, Ma L, Shang D, Liu Z, Yu Q, Wang S, Teng X, Zhang Q, Hu X, Zhao W, Hou W, Jin J, Kong FS, Yu J, Yuan S. Li L, et al. Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):940-947. doi: 10.1007/s00259-018-4143-8. Epub 2018 Sep 5. Eur J Nucl Med Mol Imaging. 2019. PMID: 30187104 Clinical Trial.

6

In Vivo Characterization of 4 ⁶⁸Ga-Labeled Multimeric RGD Peptides to Image α_vβ₃ Integrin Expression in 2 Human Tumor Xenograft Mouse Models.

Lobeek D, Franssen GM, Ma MT, Wester HJ, Decristoforo C, Oyen WJG, Boerman OC, Terry SYA, Rijpkema M. Lobeek D, et al. J Nucl Med. 2018 Aug;59(8):1296-1301. doi: 10.2967/jnumed.117.206979. Epub 2018 Apr 6. J Nucl Med. 2018. PMID: 29626124 Free PMC article.

7

Integrin αvβ3 as a Promising Target to Image Neoangiogenesis Using In-House Generator-Produced Positron Emitter (68)Ga-Labeled DOTA-Arginine-Glycine-Aspartic Acid (RGD) Ligand.

Vatsa R, Bhusari P, Kumar S, Chakraborty S, Dash A, Singh G, Dhawan DK, Shukla J, Mittal BR. Vatsa R, et al. Cancer Biother Radiopharm. 2015 Jun;30(5):217-24. doi: 10.1089/cbr.2014.1781. Cancer Biother Radiopharm. 2015. PMID: 26083951

8

Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD.

Zhang J, Niu G, Lang L, Li F, Fan X, Yan X, Yao S, Yan W, Huo L, Chen L, Li Z, Zhu Z, Chen X. Zhang J, et al. J Nucl Med. 2017 Feb;58(2):228-234. doi: 10.2967/jnumed.116.177048. Epub 2016 Aug 4. J Nucl Med. 2017. PMID: 27493267 Free PMC article.

9

Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.

Jeong JM, Hong MK, Chang YS, Lee YS, Kim YJ, Cheon GJ, Lee DS, Chung JK, Lee MC. Jeong JM, et al. J Nucl Med. 2008 May;49(5):830-6. doi: 10.2967/jnumed.107.047423. Epub 2008 Apr 15. J Nucl Med. 2008. PMID: 18413379 Free article.

10

Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRI.

Kim YI, Yoon HJ, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kim EE, Moon WK, Kang KW. Kim YI, et al. Clin Nucl Med. 2016 Aug;41(8):614-20. doi: 10.1097/RLU.0000000000001274. Clin Nucl Med. 2016. PMID: 27276207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed